Analytik Jena Appoints New MD at Japanese Subsidiary
News Dec 09, 2013
Mr. Tilgner, who will report in his future role to Analytik Jena Chief Executive Officer Klaus Berka, already took over responsibility for finance and administration at the subsidiary two months ago as its CFO as part of comprehensive restructuring measures.
"Marco Tilgner has international experience in the areas of finance and business management. He has also worked in Asia over many years and especially developed firm roots in Japan. His primary task will now be to implement the restructuring measures that are needed at our Japanese subsidiary in a consistent manner and to position AJ Japan effectively," said Klaus Berka.
The previous managing director, Yoshiharu Tada, who had led AJ Japan since its foundation in 2007 and built up the company successfully, will leave the company as planned at the end of the calendar year when he retires. Berka thanked Tada for his tireless dedication in building the subsidiary. Analytik Jena is represented in Japan with its two core business units, Analytical Instrumentation and Life Science. In the past business year, total revenue of approximately EUR 5.5 m was generated here. AJ Japan was, however, not able to meet the expectations of the parent company as part of changed regulatory conditions for measuring radioactive cesium with X-ray fluorescence devices, that were included as sales product into the portfolio after the Fukushima catastrophe.
In reaction to the overall negative developments, Analytik Jena had already begun a comprehensive program of reorganization and cost reduction before the end of the past financial year. The focus now lies on structures concentrating on cost and revenue as well as new sales initiatives in addition to the changes that have been made to the management. Analytik Jena expects its Japanese subsidiary to reach operative break even in the fourth quarter of the current 2013/2014 financial year once these measures have been implemented.
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Enterome and Nestlé Health Sciences Launch New Diagnostics CompanyNews
Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018